Search

everythinglearnresearchcommunity

for

Search:↓

A child with rickets and hair loss might have a rare type of rickets that doesn't improve much with usual vitamin D and calcium treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Four-amino acid part makes enzyme sensitive to finasteride.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Plet-1 protein helps hair follicle cells move and stick to tissues.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Ecklonia cava, a type of seaweed, may help hair grow.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

Finasteride effectively treats hair loss in Korean men for at least 5 years, with V type responding better.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.